US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

265.79

+4.791.84%

Post-market: 266.500.7100+0.27%19:59 EDT

Volume:295.12K

Turnover:79.09M

Market Cap:604.54M

PE:- -

High:276.21

Open:265.34

Low:259.25

Close:261.00

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:0.66

T/O Rate:12.98%

Dividend:0.91

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Roche’s Genentech announces FDA approves NDA for fenebrutinib

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)

Health Care Roundup: Market Talk

Yamashita Health Care Sees FY Net Y553.00m

HUTCHMED Shares Rise Over 3% After Announcing FDA Submission for Orpathys and Tagrisso Combination Therapy

IHH Healthcare's Recent Weakness Likely Offers a Buying Opportunity

Golden Globe Resources Sets Date and Digital Framework for 2026 AGM

Vectus wins FDA pre-IND green light for VB0004 in IPF

Telix Wins FDA Fast Track for Pre-Biopsy Prostate Cancer Imaging Program

DBV Technologies submits BLA to FDA for Viaskin Peanut Patch

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Healthcare Stocks Declined as Consumer Confidence Slips

Health Care Roundup: Market Talk

Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary

Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim

Neogen issued FDA warning letter for Neogen Vet HYCOAT

Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path

Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)

Health Care Roundup: Market Talk

Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":265.79,"timestamp":1790798400000,"preClose":261,"halted":0,"volume":295118,"hourTrading":{"tag":"盘后","latestPrice":266.5,"preClose":265.79,"latestTime":"19:59 EDT","volume":2105,"amount":559351.6497,"timestamp":1790812786487,"change":0.71,"changeRate":0.002671,"amplitude":0.007525},"delay":0,"changeRate":0.01835249042145602,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Not Yet Opened","change":4.79,"latestTime":"09-30 16:00:00 EDT","open":265.34,"high":276.21,"low":259.25,"amount":79086093.48868,"amplitude":0.064981,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":261,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.003437,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":267.3071,"preClose":261,"latestTime":"09:29 EDT","volume":2136,"amount":561658.99992,"timestamp":1790774957184,"change":6.3071,"changeRate":0.024165,"amplitude":0.030334},"postHourTrading":{"tag":"盘后","latestPrice":266.5,"preClose":265.79,"latestTime":"19:59 EDT","volume":2105,"amount":559351.6497,"timestamp":1790812786487,"change":0.71,"changeRate":0.002671,"amplitude":0.007525},"volumeRatio":0.663023,"impliedVol":0.9528,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.663023,"shares":2274486,"dividePrice":0.9135,"high":276.21,"amplitude":0.064981,"preClose":261,"low":259.25,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":265.79,"eps":0,"divideRate":0.003437,"volume":295118,"delay":0,"ttmEps":0,"open":265.34,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":253.11,"twentyDayClose":300.7,"sixtyDayClose":322.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671220846","title":"Roche’s Genentech announces FDA approves NDA for fenebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220846","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220846?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:50","pubTimestamp":1790761812,"startTime":"0","endTime":"0","summary":"Genentech, a member of the Roche (RHHBY) Group, announced that the U.S. FDA has accepted the company’s NDA under priority review for fenebrutinib, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","BK4585","HRTS","BK4588","LABU","03165","RHHBY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671724342","title":"Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671724342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671724342?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:50","pubTimestamp":1790758222,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), Tectonic Therapeutic (TEC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BK4568","SG9999002232.USD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU2237957811.SGD","IE0002141913.USD","LU1670628061.USD","SG9999004303.SGD","LU0266013472.USD","IE00BJJMRZ35.SGD","XBI","BK4533","LU0211331839.USD","LU1914381329.SGD","TMED","HCSG","LU1721429741.USD","LU2468319806.SGD","LU1023059063.AUD","TECX","PJP","LU0432979614.USD","LU0868494617.USD","LU1721429402.USD","LU0882574055.USD","LU2133065610.SGD","LU0128526141.USD","LU0208291251.USD","BK4588","LU0114720955.EUR","LU1057294990.SGD","IE00B2B36J28.USD","LU0170899867.USD","LU2089984988.USD","LU0289739699.SGD","LU0320765489.SGD","XLV","BK4585","BK4581","LU1989763690.USD","IE00BFTCPJ56.SGD","BK4137","BK4139","IHI","LABU","LU2112291526.USD","ABT","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671027487","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671027487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671027487?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:20","pubTimestamp":1790756400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0749 GMT - Fresenius investors might have overreacted to news th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","PMDE","BK4585","XBI","DECU","VOTE","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671275727","title":"Yamashita Health Care Sees FY Net Y553.00m","url":"https://stock-news.laohu8.com/highlight/detail?id=2671275727","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671275727?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:00","pubTimestamp":1790751600,"startTime":"0","endTime":"0","summary":"Yamashita Health Care Holdings Inc. also released the following forecasts:. Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XLV","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122605627","title":"HUTCHMED Shares Rise Over 3% After Announcing FDA Submission for Orpathys and Tagrisso Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1122605627","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122605627?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:02","pubTimestamp":1790737370,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) shares rose more than 3%, reaching HK$23.04 as of press time, up 3.32%, with a turnover of HK$69.44 million.On September 29, HUTCHMED (00013) announced that AstraZeneca has submitted...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK4588","BK4585","BK1191","LABU","IPOS","VXUS","KCAI","BK1587","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221962","title":"IHH Healthcare's Recent Weakness Likely Offers a Buying Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221962?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:11","pubTimestamp":1790734260,"startTime":"0","endTime":"0","summary":"0211 GMT - IHH Healthcare's recent share price weakness is likely an enhanced buying opportunity, with Fortis-related litigation concerns expected to have limited impact on operations, says Citi analyst Megat Fais in a note. IHH says it isn't subject to financial claims in the dispute involving Daiichi Sankyo and former Fortis promoters. IHH's India plans remain on track to reach 10,000 beds target by 2030-2031, while Singapore's recovery is expected to continue, he reckons. Malaysia should see growth from selective bed additions and medical tourism, while Turkey's strong demand and international patient flows are expected to continue, he adds. Citi keeps a buy rating and its target price at 10.40 ringgit. Shares are 0.1% higher at 7.88 ringgit.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0029874061.USD","DSNKY","LU0128526141.USD","BK4007","BK4581","BK4588","HCSG","LABU","XLV","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671044225","title":"Golden Globe Resources Sets Date and Digital Framework for 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2671044225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671044225?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:23","pubTimestamp":1790727806,"startTime":"0","endTime":"0","summary":"Reckon Health Care Holdings Ltd ( ($AU:GGR) ) has shared an announcement. Golden Globe Resources Limited has convened its 2026 Annual General Meeti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-sets-date-and-digital-framework-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-sets-date-and-digital-framework-for-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223279","title":"Vectus wins FDA pre-IND green light for VB0004 in IPF","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223279","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223279?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:58","pubTimestamp":1790726292,"startTime":"0","endTime":"0","summary":"Vectus Biosystems Limited ( ($AU:VBS) ) has provided an announcement. Vectus Biosystems has secured a pre-Investigational New Drug Type B meeting w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vectus-wins-fda-pre-ind-green-light-for-vb0004-in-ipf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vectus-wins-fda-pre-ind-green-light-for-vb0004-in-ipf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228076","title":"Telix Wins FDA Fast Track for Pre-Biopsy Prostate Cancer Imaging Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228076","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228076?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:15","pubTimestamp":1790723736,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA Fast Track designation for its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-fast-track-for-pre-biopsy-prostate-cancer-imaging-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-fast-track-for-pre-biopsy-prostate-cancer-imaging-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","TLX","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228597","title":"DBV Technologies submits BLA to FDA for Viaskin Peanut Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228597","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228597?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:35","pubTimestamp":1790721319,"startTime":"0","endTime":"0","summary":"DBV Technologies (DBVT) announced that the company has submitted a Biologics License Application to the U.S. FDA for the Viaskin Peanut Patch in ch...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dbv-technologies-submits-bla-to-fda-for-viaskin-peanut-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dbv-technologies-submits-bla-to-fda-for-viaskin-peanut-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBVT","BK4139","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671942228","title":"DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2671942228","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671942228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:29","pubTimestamp":1790720940,"startTime":"0","endTime":"0","summary":"Chtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for theVIASKIN Peanut Patch in Children Aged 4-7 Years  TheBLAis supportedbyther","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3371452/0/en/dbv-technologies-announces-submission-of-biologics-license-application-to-u-s-fda-for-the-viaskin-peanut-patch-in-children-aged-4-7-years.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","NVIB","LABU","BK4588","IDNA","MEDX","BK4585","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247293","title":"Healthcare Stocks Declined as Consumer Confidence Slips","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247293?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:58","pubTimestamp":1790715480,"startTime":"0","endTime":"0","summary":"On a losing day in Wall Street, the healthcare industry was no exemption. Stocks fell amid a surprising decline in the Conference Board Consumer Confidence Index.UniQure slid after patients treated with its Huntington's disease drug in a recent study no longer showed a statistically significant slowdown in disease-induced decline after four years. At four years, the study's primary endpoint--composite Unified Huntington's Disease Rating Scale --showed a 44% slowing of disease progression compared with an external control, but the data did not reach statistical significance, the company said.Novo Nordisk has signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion. The Danish drugmaker will pay China-based Hengrui $300 million upfront, with the rest of the potential deal value tied to milestones. Novo will obtain exclusive rights to develop, manufacture and commercialize HRS-1596 globally, excluding mainland China, Hong","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","LABU","BK4581","LU0128526141.USD","LU0029874061.USD","BK4585","XLV","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247428","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247428?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:50","pubTimestamp":1790715000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671241431","title":"Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2671241431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671241431?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:03","pubTimestamp":1790705014,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ). Max Healthcare Institute Ltd has updated exchanges on ongoing...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","LU0128526141.USD","BK4585","XLV","BK4588","LABU","BK4581","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324954","title":"Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324954?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:15","pubTimestamp":1790702111,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Subbu Nambi notes that Neogen (NEOG) shares sold off after the FDA issued warning letter related to Neogen Vet HYCOAT for veteri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogen-selloff-after-fda-warning-letter-overdone-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogen-selloff-after-fda-warning-letter-overdone-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NEOG","LABU","PJP","LU2211817866.USD","BK4585","BK4588","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671249510","title":"Neogen issued FDA warning letter for Neogen Vet HYCOAT","url":"https://stock-news.laohu8.com/highlight/detail?id=2671249510","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671249510?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:10","pubTimestamp":1790701811,"startTime":"0","endTime":"0","summary":"The FDA posted a warning letter, dated September 23, to its site earlier that states in part: “This Warning Letter summarizes significant violation...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogen-issued-fda-warning-letter-for-neogen-vet-hycoat-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogen-issued-fda-warning-letter-for-neogen-vet-hycoat-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","PJP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246794","title":"Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246794","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246794?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:55","pubTimestamp":1790700918,"startTime":"0","endTime":"0","summary":"Immix Biopharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham reiterated a Buy rating...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671743246","title":"Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671743246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671743246?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:40","pubTimestamp":1790700010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","BK4588","BK4139","BK4539","XBI","XLV","LU0029874061.USD","NAMS","LABU","BK4581","LU0128526141.USD","IVVD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246586","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246586?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:20","pubTimestamp":1790698800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671924571","title":"Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2671924571","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671924571?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:06","pubTimestamp":1790697960,"startTime":"0","endTime":"0","summary":"Neogen received warning letters from the Food and Drug Administration following an investigation that linked a vet wound care product labeled as sterile to serious infections and deaths in horses.The ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","NEOG","LU2211817866.USD","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":3,"totalSize":397,"code":"91000000","status":"200"}]}}